Business Description
TWi Biotechnology Inc
ISIN : TW0006610009
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 33.35 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -20.2 | |||||
3-Year EPS without NRI Growth Rate | -17.1 | |||||
3-Year FCF Growth Rate | -11.6 | |||||
3-Year Book Growth Rate | -2.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.31 | |||||
9-Day RSI | 39.59 | |||||
14-Day RSI | 41.75 | |||||
6-1 Month Momentum % | 15.04 | |||||
12-1 Month Momentum % | -9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.71 | |||||
Quick Ratio | 4.71 | |||||
Cash Ratio | 4.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.7 | |||||
Shareholder Yield % | -0.47 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -90.62 | |||||
ROA % | -76.54 | |||||
ROIC % | -324.43 | |||||
ROC (Joel Greenblatt) % | -3054.88 | |||||
ROCE % | -88.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.79 | |||||
Price-to-Tangible-Book | 5.61 | |||||
EV-to-EBIT | -4.16 | |||||
EV-to-EBITDA | -4.35 | |||||
EV-to-FCF | -5.01 | |||||
Price-to-Net-Current-Asset-Value | 6.65 | |||||
Price-to-Net-Cash | 6.68 | |||||
Earnings Yield (Greenblatt) % | -24.03 | |||||
FCF Yield % | -16.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TWi Biotechnology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | |||
EPS (TTM) (NT$) | -2.83 | ||
Beta | 0.24 | ||
Volatility % | 31.27 | ||
14-Day RSI | 41.75 | ||
14-Day ATR (NT$) | 0.41757 | ||
20-Day SMA (NT$) | 13.6325 | ||
12-1 Month Momentum % | -9 | ||
52-Week Range (NT$) | 11.15 - 16.4 | ||
Shares Outstanding (Mil) | 87.65 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TWi Biotechnology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TWi Biotechnology Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
TWi Biotechnology Inc Frequently Asked Questions
What is TWi Biotechnology Inc(ROCO:6610)'s stock price today?
When is next earnings date of TWi Biotechnology Inc(ROCO:6610)?
Does TWi Biotechnology Inc(ROCO:6610) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |